"I may have been swayed if this represented a major advance in the field," said panelist Walter Dunn, MD, PhD, of the ...

The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...

The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...

An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...

PTSD. Learn how trauma fuels chronic shame—and how to change the narrative. Reclaim your voice with compassion and ...

Classical psychedelics like LSD, psilocybin, and mescaline are known for activating the 5-HT2A serotonin receptor, but a new ...

The U.S. Food and Drug Administration's reviewers have raised efficacy concerns over Otsuka Pharma's combination drug for ...

Rebirth, for much of its runtime, remains in metaphor. It’s concerned with things that we don’t directly say but that have an ...

A controversial treatment offers a painless route to ridding veterans of their trauma responses. But does it really work?

A large genetic study reveals that cannabis use disorder (CanUD) is strongly linked to increased risk for multiple psychiatric disorders, including depression, PTSD, ADHD, and schizophrenia.

Kratom and its powerful metabolite, 7-hydroxymitragynine (7OH), offer unique therapeutic benefits—from mood support to pain ...

As record wildfires erupt across Canada this year, with health-threatening smoke drifting into the U.S. and as far away as ...